Impact of the COVID-19 Pandemic on Global TAVR Activity: The COVID-TAVI Study

Xavier Armario1, Jennifer Carron2, Andrew J Simpkin3

  • 1Department of Cardiology, Galway University Hospital, Galway, Ireland; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.

PubMed

Insights

The COVID-19 pandemic significantly reduced transcatheter aortic valve replacement (TAVR) procedures globally during its first two waves. Reductions were most pronounced in Africa, Central-South America, and Asia, influenced by socioeconomic factors and public health responses.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • The COVID-19 pandemic disrupted global healthcare systems, impacting essential medical procedures.
  • Patients requiring transcatheter aortic valve replacement (TAVR) faced significant risks of treatment delays.

Purpose of the Study:

  • To assess the global impact of the COVID-19 pandemic on transcatheter aortic valve replacement (TAVR) activity.
  • To identify factors associated with changes in TAVR procedural volumes during the pandemic.

Main Methods:

  • An international registry collected monthly TAVR case volumes from January 2018 to December 2021.
  • Data included hospital characteristics (public/private, urban/rural, volume) and country-level factors (socioeconomic status, COVID-19 incidence, public health responses).

Main Results:

  • Global TAVR activity decreased by 15% and 7% during the first and second pandemic waves, respectively.
  • Significant reductions were observed in Africa (-52%), Central-South America (-33%), and Asia (-29%).
  • Greater reductions occurred in private hospitals, urban areas, low-volume centers, less developed countries, and regions with higher COVID-19 incidence and stricter public health measures.

Conclusions:

  • Transcatheter aortic valve replacement (TAVR) procedural volumes substantially declined during the initial COVID-19 waves, particularly in Africa, Central-South America, and Asia.
  • National socioeconomic status, COVID-19 incidence, and public health interventions influenced TAVR activity.
  • Findings offer insights for public health policy during future global health crises.
Abstract